Cereblon and IRF4 Variants Affect Risk and Response to Treatment in Multiple Myeloma

Overview of attention for article published in Archivum Immunologiae et Therapiae Experimentalis, January 2017

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (55th percentile)

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 19,157 followers.

Cereblon and IRF4 Variants Affect Risk and Response to Treatment in Multiple Myeloma. https://t.co/BNo6YOBF6V https://t.co/1YQNBuyWVi

RT @Myeloma_Doc: Cereblon and IRF4 polymorphisms may impact upon the risk of developing #myeloma and its response to therapy: https://t.co/…

RT @Myeloma_Doc: Cereblon and IRF4 polymorphisms may impact upon the risk of developing #myeloma and its response to therapy: https://t.co/…

Cereblon and IRF4 polymorphisms may impact upon the risk of developing #myeloma and its response to therapy: https://t.co/knC8QF6rSc.